Riskpilot← Back to searchSign inGet full accessTHEVITO AS
ASActiveOrg 828460072Gartnerveien 12, 1356 BekkestuaMedical specialists activities · NACE 8622Est. 20211 employees
Revenue 2025
NOK 8,5M
+4% vs 2024
EBITDA margin
36.0%
0% vs 2024
Equity ratio
82.9%
Financial strength
Net profit 2025
NOK 2M
-16% vs 2024
| Revenue | NOK 8,5M | +4% |
| EBITDA | NOK 3,1M | +0% |
| Net profit | NOK 2M | -16% |
| Total assets | NOK 9,4M | +17% |
| Equity | NOK 7,8M | +24% |
| Employees | 1 | — |
Legal name
THEVITO AS
Org number
828460072
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
31. desember 2021
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Drift av øyelegepraksis og andre relaterte helsetjenester, investering og deltakelse i andre selskaper og eiendom, samt alt annet som naturlig faller inn under dette.
Address
Gartnerveien 12, 1356 Bekkestua
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 9 307 | 7 854 | 8 247 | 8 537 |
| Staff expenses | −0 | −1 424 | −912 | −805 | −807 |
| EBITDA | 0 | 3 708 | 2 784 | 3 082 | 3 073 |
| Depreciation & amort. | −0 | −0 | −8 | −16 | −84 |
| EBIT | 0 | 3 708 | 2 776 | 3 066 | 2 989 |
| Net financials | 0 | 0 | −10 | 8 | −277 |
| Profit before tax | 0 | 3 708 | 2 766 | 3 074 | 2 712 |
| Tax | −0 | 816 | 613 | 679 | 691 |
| Net profit | 0 | 2 893 | 2 153 | 2 396 | 2 021 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 30 | 4 278 | 6 048 | 7 986 | 9 383 |
| Equity | 19 | 2 711 | 4 565 | 6 260 | 7 781 |
| Long-term debt | 0 | 2 | 3 | 8 | 26 |
| Short-term debt | 11 | 1 565 | 1 481 | 1 717 | 1 575 |
| Total debt | 11 | 1 567 | 1 484 | 1 726 | 1 601 |
EBITDA margin
36.0%
This company
15.8%
Market median
+128% vs market
20212025
Equity ratio
82.9%
This company
38.2%
Market median
+117% vs market
20212025
Return on equity
26.0%
This company
18.4%
Market median
+41% vs market
20212025
Net profit margin
23.7%
This company
8.1%
Market median
+193% vs market
20212025
Asset turnover
0.91×
This company
1.12×
Market median
+19% vs market
20212025
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-10-27 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RF Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of THEVITO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Reier Fredrik Schøne | Chief Executive Officer | 0 companies |
| Linda Maria Romundstad | Board of Directors | 0 companies |